A Four-Component Research Formulation
The Klow Blend is a proprietary research formulation combining four distinct peptide research compounds into a single lyophilized preparation: BPC-157 (10 mg), TB-500 (10 mg), GHK-Cu (50 mg), and KPV (10 mg). Because "Klow Blend" is proprietary SDC Biolabs terminology, this compound owns its search term outright — no other vendor produces a compound under this name. This article is the canonical research reference for the formulation.
The research rationale for a four-component blend is the hypothesis that four mechanistically distinct signaling nodes, studied concurrently in laboratory models, produce a research readout no single component yields in isolation. The design question is which signaling axes, combined, are most informative for the experimental objective.
Component 1 — BPC-157
BPC-157 (molecular formula C₆₂H₉₈N₁₆O₂₂; CAS 137525-51-0) is a pentadecapeptide of 15 amino acids first isolated from human gastric juice, with an extensive literature base of more than 700 published studies. Its research profile centers on angiogenesis and growth factor signaling modulation — VEGF and FGF pathways relevant to vascularization and tissue-model research. BPC-157 is the angiogenesis and cytoprotective node of the Klow Blend.
Component 2 — TB-500 (Thymosin Beta-4)
TB-500 (molecular formula C₂₁₂H₃₅₀N₅₆O₇₈S; CAS 107761-42-2) is a synthetic version of Thymosin Beta-4, an actin-binding protein. Thymosin Beta-4 sequesters globular actin (G-actin), and its research profile centers on actin regulation and cellular migration — the capacity of cells to move and reorganize. Where BPC-157 addresses the vascularization question, TB-500 addresses the cellular movement and cytoskeletal organization question.
Component 3 — GHK-Cu
GHK-Cu (molecular formula C₁₄H₂₄CuN₆O₄; CAS 89030-95-5) is a copper-chelation tripeptide (glycyl-L-histidyl-L-lysine bound to copper (II)). Its research profile centers on extracellular matrix remodeling and collagen synthesis modulation — fibroblast collagen expression, lysyl oxidase cofactor biology, and dermal/ECM model readouts. GHK-Cu adds the structural-matrix signaling node.
Component 4 — KPV (Lys-Pro-Val)
KPV (molecular formula C₁₅H₂₅N₄O₄; CAS 69679-15-8) is a tripeptide composed of lysine, proline, and valine, representing the C-terminal tripeptide of alpha-melanocyte stimulating hormone (α-MSH). Its research profile centers on melanocortin receptor binding and anti-inflammatory signaling pathway interactions. KPV is studied in the context of the melanocortin system — the same receptor family studied with PT-141 and Melanotan II — but KPV's research focus is signaling pathway interactions rather than the central melanocortin signaling studied with those cyclic peptides.
KPV is the inflammatory-signaling node of the Klow Blend — the component that engages the melanocortin axis where the other three components engage angiogenesis, actin, and ECM biology respectively.
Why Researchers Combine These Four
The conceptual map of the Klow Blend is:
| Component | Research node | Signaling axis | | --- | --- | --- | | BPC-157 | Angiogenesis | VEGF / FGF growth factor signaling | | TB-500 | Cellular migration | Actin regulation (Thymosin Beta-4) | | GHK-Cu | Extracellular matrix | Collagen synthesis / lysyl oxidase | | KPV | Inflammatory signaling | Melanocortin receptor binding |
Each component engages a distinct signaling axis. The research hypothesis encoded in the blend is that concurrent study of vascularization (BPC-157), cellular movement (TB-500), structural matrix (GHK-Cu), and inflammatory signaling (KPV) produces a more complete regenerative research readout than any single axis studied in isolation. This is a hypothesis — the value of the four-axis design is itself a subject of laboratory investigation.
Comparison to the Glow Blend and Wolverine Stack
The Klow Blend sits at the top of SDC Biolabs' blended research formulation hierarchy:
- Wolverine Stack — BPC-157 + TB-500 only. Two-axis (angiogenesis + actin).
- Glow Blend — BPC-157 + TB-500 + GHK-Cu. Three-axis, adding ECM/collagen.
- Klow Blend — BPC-157 + TB-500 + GHK-Cu + KPV. Four-axis, adding melanocortin/inflammatory signaling.
The progression is cumulative: each formulation adds a signaling node. The choice between them is a choice of how many concurrent axes the experimental design calls for.
Research Framing
The Klow Blend is supplied for laboratory and scientific research use only. It is not for human consumption, is not a pharmaceutical, and is not approved by the FDA for any medical use. The combined signaling profile is a research hypothesis, not a claim of effect. Purchasers must be 21 years of age or older.